8-K


 
 
 
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
   
 
FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): April 21, 2016
   
 
INTUITIVE SURGICAL, INC.
(Exact name of registrant as specified in its charter)
 
  
  
  
  
  
Delaware 
   
000-30713 
   
77-0416458 
(State or other jurisdiction
of incorporation)
   
(Commission File Number)
   
(I.R.S. Employer Identification No.)

  
1020 Kifer Road
Sunnyvale, California 94086
(Address of principal executive offices) (zip code)
    

Registrant’s telephone number, including area code: (408) 523-2100

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 







Item 5.02.    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) Compensatory Arrangements of Certain Officers.

Approval of the Amendment and Restatement of the 2010 Incentive Award Plan
The Board of Directors of Intuitive Surgical, Inc. (the “Company”) previously adopted, subject to stockholder approval, an increase in the number of shares of common stock reserved for issuance pursuant to awards granted under the Company’s 2010 Incentive Award Plan (the “2010 Plan”) from 6,250,000 to 7,050,000 (the “Award Pool Increase”). At the Company’s Annual Meeting of Stockholders held on April 21, 2016 (the “Annual Meeting”), the Company’s stockholders approved the amendment and restatement of the 2010 Plan including the Award Pool Increase. The foregoing description of the 2010 Plan, as amended and restated, is qualified in its entirety by reference to the text of the amended and restated 2010 Plan, which is filed as Exhibit 10.1 hereto and incorporated herein by reference.

Item 5.07.    Submission of Matters to a Vote of Security Holders
 
At the Annual Meeting, the stockholders of the Company voted on the following four proposals, each of which is described in detail in the Company’s definitive proxy statement and amendment thereto, filed with the Securities and Exchange Commission on March 7, 2016 and April 18, 2016, respectively:

Proposal No. 1: To elect nine members to the Board of Directors to serve a one-year term expiring at the 2017 Annual Meeting of Stockholders:
Nominee
 
For
 
Withheld
 
Broker Non-votes
Craig H. Barratt, Ph.D.
 
31,882,949
 
90,265
 
2,649,749
Michael A. Friedman, M.D.
 
31,867,252
 
105,962
 
2,649,749
Gary S. Guthart, Ph.D.
 
31,882,498
 
90,716
 
2,649,749
Amal M. Johnson
 
31,706,398
 
266,816
 
2,649,749
Keith R. Leonard, Jr.
 
31,746,763
 
226,451
 
2,649,749
Alan J. Levy, Ph.D.
 
31,484,396
 
488,818
 
2,649,749
Mark J. Rubash
 
31,883,850
 
89,364
 
2,649,749
Lonnie M. Smith
 
31,687,460
 
285,754
 
2,649,749
George Stalk, Jr.
 
31,884,187
 
89,027
 
2,649,749

Each of the nominees recommended in Proposal No. 1 was elected.
    

Proposal No. 2: To approve, by an advisory vote, the compensation of the Company’s named executive officers:

For
 
Against
 
Abstain
 
Broker Non-votes
31,041,254
 
907,939
 
24,021
 
2,649,749

Proposal No. 2 was approved.
    

Proposal No. 3: To ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016:
For
 
Against
 
Abstain
34,584,538
 
25,321
 
13,104

Proposal No. 3 was approved.





Proposal No. 4: To approve an amendment and restatement of the Company’s 2010 Incentive Award Plan:

For
 
Against
 
Abstain
 
Broker Non-votes
22,154,851
 
9,788,505
 
29,858
 
2,649,749

Proposal No. 4 was approved.

Item 9.01.    Financial Statements and Exhibits
 
(d) Exhibits
Exhibit Number
  
Description
10.1
 
Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated







SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  
  
  
  
  
  
  
  
  
  
  
  
  
INTUITIVE SURGICAL, INC.
 
 
 
 
 
  
  
 
  
 
  
 
Date: April 26, 2016
  
  
  
By:
  
/s/ Marshall L. Mohr
  
  
  
  
  
  
  
  
  Name: Marshall L. Mohr
  
  
  
  
  
  
  
  
  Title: Senior Vice President and Chief Financial Officer


 
 
 
 
 
 
 
 
 

 





EXHIBIT INDEX
Exhibit No.
  
Description
10.1
 
Intuitive Surgical, Inc. 2010 Incentive Award Plan, as amended and restated.